Clinical reference Biomarker Directory
Back to directory

SS-A/Ro Antibodies

Established

SS-A/Ro is the key Sjogren's syndrome marker, with an important congenital heart block risk in pregnancy.

Also known as Anti-SS-A anti-Ro antibody
In plain language

This antibody is the main marker for Sjogren's syndrome, a condition causing dry eyes and mouth. It has an important extra consideration for pregnancy: it can cross into the developing baby and affect the baby's heart rhythm, so doctors monitor these pregnancies more closely even if the mother has no diagnosed autoimmune disease herself.

Biomarker & context

Anti-SS-A/Ro antibodies target a ribonucleoprotein complex and are the key diagnostic serologic marker for Sjogren's syndrome, an autoimmune condition causing dry eyes and dry mouth from immune-mediated gland damage.

What it indicates

Positive SS-A/Ro supports Sjogren's syndrome diagnosis, but carries a distinct and important obstetric implication beyond the primary disease: in pregnant patients, these antibodies can cross the placenta and cause congenital heart block in the fetus, making maternal antibody status relevant to prenatal monitoring even in women without an established autoimmune diagnosis.

Diagnosis & clinical testing

Measured via immunoassay as part of an extractable nuclear antigen (ENA) panel, often alongside SS-B/La; pregnant patients with known SS-A/Ro positivity (from any cause, including asymptomatic carriers) typically undergo serial fetal echocardiography during a defined window of pregnancy to monitor for developing heart block.

Guiding treatment

Confirmed congenital heart block risk in an SS-A/Ro-positive pregnancy prompts specialist obstetric/cardiology monitoring; some at-risk pregnancies are managed with hydroxychloroquine, which has shown promise in reducing heart block risk in affected pregnancies.

Clinical significance

Relevant to prenatal monitoring even in asymptomatic antibody-positive women without a diagnosed autoimmune condition.

References
  1. General rheumatology and maternal-fetal medicine reference literature on SS-A/Ro antibodies, Sjogren's syndrome, and congenital heart block risk.